Rallybio Corporation Registered Shs Aktie
WKN DE: A3CWDP / ISIN: US75120L1008
29.06.2023 14:43:29
|
Rallybio Says Co-founder Stephen Uden To Replace Martin Mackay As CEO
(RTTNews) - Rallybio Corporation (RLYB), a clinical-stage biotechnology company focused on developing therapies for severe and rare diseases, announced on Thursday that its MD, COO, and co-founder Stephen Uden will assume the role of Chief Executive Officer starting August 1. The transition will see Martin Mackay, the current CEO, taking on the position of Executive Chairman.
As CEO, Uden will continue as President and oversee Rallybio's strategic operations.
Prior to joining Rallybio, Uden held the position of Head of Research at Alexion Pharmaceuticals, Inc.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Rallybio Corporation Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Rallybio Corporation Registered Shsmehr Analysen
Aktien in diesem Artikel
Rallybio Corporation Registered Shs | 0,29 | 0,00% |
|